CME Group (Nasdaq: CME ) is expected to report Q4 earnings on Feb. 5. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict CME Group's revenues will wither -9.8% and EPS will compress -9.9%.
The average estimate for revenue is $664.1 million. On the bottom line, the average EPS estimate is $0.64.
Last quarter, CME Group logged revenue of $683.2 million. GAAP reported sales were 22% lower than the prior-year quarter's $874.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.70. GAAP EPS of $0.66 for Q3 were 31% lower than the prior-year quarter's $0.95 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 97.2%, 20 basis points worse than the prior-year quarter. Operating margin was 58.0%, 740 basis points worse than the prior-year quarter. Net margin was 31.9%, 430 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $2.92 billion. The average EPS estimate is $3.01.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 769 members out of 819 rating the stock outperform, and 50 members rating it underperform. Among 227 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 216 give CME Group a green thumbs-up, and 11 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CME Group is outperform, with an average price target of $58.94.
Can your portfolio provide you with enough income to last through retirement? You'll need more than CME Group. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add CME Group to My Watchlist.